Rubius Therapeutics | 15-12G:終止註冊
Rubius Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(0.329%),Abigail P. Johnson(0.329%)
Rubius Therapeutics | 8-K:重大事件
Rubius Therapeutics | 25:註銷已到期、已贖回、已兌付證券的通知
Rubius Therapeutics | DEF 14A:股東委託書決議
Rubius Therapeutics | 8-K:重大事件
Rubius Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Baillie Gifford & Co (Scottish partnership)(0%)
Rubius Therapeutics | PRER14A:初步修訂代理權徵集材料
Rubius Therapeutics | 4:持股變動聲明
Rubius Therapeutics | PRE 14A:並購重組委托聲明
Rubius Therapeutics | 10-K:2022財年年報
Rubius Therapeutics | S-8 POS:員工福利計劃證券登記(修正)
Rubius Therapeutics | S-8 POS:員工福利計劃證券登記(修正)
Rubius Therapeutics | S-8 POS:員工福利計劃證券登記(修正)
Rubius Therapeutics | S-8 POS:員工福利計劃證券登記(修正)
Rubius Therapeutics | S-8 POS:員工福利計劃證券登記(修正)
Rubius Therapeutics | RW:註冊提款請求
Rubius Therapeutics | 8-K:重大事件
Rubius Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Noubar B. Afeyan, Ph.D.(42.7%),Flagship Ventures Fund IV General Partner LLC(26.8%)等
Rubius Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Abigail P. Johnson(13.694%),FMR LLC(13.694%)
暫無數據
暫無數據